RoboMed – Finnish MedTech company developing robotic capsule technology for gastrointestinal endoscopy, small-intestine examination, and targeted diagnostic capabilities.
robomed.ca
LaunchIndex first observed RoboMed – Finnish MedTech company developing robotic capsule technology for gastrointestinal endoscopy, small-intestine examination, and targeted diagnostic capabilities. (robomed.ca) live on 6 October 2026. View its launch screenshot, category, technologies, and verification evidence.
A launch record built from evidence.
RoboMed – Finnish MedTech company developing robotic capsule technology for gastrointestinal endoscopy, small-intestine examination, and targeted diagnostic capabilities. (robomed.ca) was first observed live on 6 October 2026.
RoboMed is a Finnish medical robotics company developing robotic capsule technology for gastrointestinal endoscopy, small-intestine examination, and targeted diagnostic capabilities.
Its profile is classified as Professional service within Health / Health and wellness. Verification detected WordPress.
What the launch signal contained.
- First observed live
- Previous state
- No prior non-live observation
- Last verified
- Canonical host
- robomed.ca
- Category
- Health / Health and wellness
- Website type
- Professional service
- Observed title
- RoboMed – Finnish MedTech company developing robotic capsule technology for gastrointestinal endoscopy, small-intestine examination, and targeted diagnostic capabilities.
- Observed description
- Not captured
- Detected technologies
- WordPress
- Screenshot captured
- Evidence source
- Browser observation · Local
- Evidence confidence
- 93%
- HTTP status
- 200
Is this your website?
Claim this profile to add verified owner information.
What do you make of this launch?
Vote on the site and leave a short note for other people exploring the new web.
Report an issueFlag spam, illegal or harmful content, or inaccurate information.
Reports are private and reviewed by the moderation team. No sign-in is required, so this report will be anonymous.
Join the discussion
Sign in with Google to vote or comment.
Sign in to participateComments
0 commentsBe the first to leave a useful observation.